CHARLOTTE, N.C., Oct. 25, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced it will host a conference call to discuss its Byte ...

CHARLOTTE, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), today announced the voluntary suspension of sales and marketing of ...

With its Q3 2024 financials on Thursday, Dentsply Sirona (NASDAQ:XRAY) met Street forecasts but slashed its full-year outlook, prompting Leerink Partners to downgrade the dental care company to ...

Needham analyst David Saxon maintained a Buy rating on DENTSPLY SIRONA (XRAY – Research Report) today and set a price target of $23.00. David Saxon has given his Buy rating due to a combination ...

Baird lowered the firm’s price target on Dentsply Sirona (XRAY) to $24 from $31. The firm said with implant and equipment pressures continuing, shares were likely going to be down today.

CHARLOTTE, N.C., Nov. 07, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2024.

Dentsply Sirona's Q3 earnings beat estimates, but a $495M goodwill impairment and lower sales outlook weigh on results. Dentsply revises FY24 outlook, citing market pressures and Byte-related ...

Shares of Dentsply Sirona Inc. XRAY slid 1.18% to $17.65 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.10% to 6,001.35 ...

Good day, and thank you for standing by. Welcome to the Quarter Three 2024 DENTSPLY SIRONA Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers ...

Dentsply Sirona Misses Q2 Targets - Plans Restructuring Plan Amid Weak Demand Dentsply Sirona misses Q2 earnings, announces restructuring amid weak demand.